AMSBIO, a leading provider of innovative products and services for the life sciences community, announces the launch of its Expanded Stem Cell Synergy Solutions.
Over the last two decades AMSBIO has established itself as a leading international supplier of solutions for streamlined and efficient ES/iPS Cell Culture using feeder-free StemFit® media and iMatrix recombinant laminin extracellular matrices. Backed by knowledgeable support teams in the UK, USA, and Germany – AMSBIO has expanded its products and services across the entire stem cell workflow, from sourcing and growing to storing, differentiating, and manufacturing.
AMSBIO offers an extensive range of sources to facilitate cutting-edge stem cell research. including fresh tissues covering a wide range of donors and disease states, cell lines and a custom pluripotent stem cell (iPSC) generation service. By segmenting the stem cell workflow, AMSBIO supports researchers by simplifying the procurement process and providing valuable guidance at each stage of your stem cell research.
Discover everything you need for stem cell culture with superior expansion rates whilst maintaining genetic stability, as well as reliable solutions for long-term cryopreservation. In addition, AMSBIO offers an extensive range of leading-edge cryopreservation solutions that guarantee the integrity of your cells. For efficient stem cell differentiation toward specific cell lineages from PSCs, AMSBIO offers a specially curated differentiation product range.
Stem Cell Synergy Solutions from AMSBIO
To seamlessly transition your research to deployment in clinical applications – AMSBIO offer a suite of GMP-compliant manufacturing products and services trusted by a growing group of leading pharma and biotech organizations.
To learn more about Stem Cell Synergy solutions please visit https://www.amsbio.com/stem-cells/expanded-stem-cell-synergy/ or contact AMSBIO on +31-72-8080244 / +44-1235-828200 / +1-617-945-5033 / [email protected].
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products, and services for R&D in the medical, nutrition, cosmetics, and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion, and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. For drug discovery research, AMSBIO offers assays, recombinant proteins, and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognized as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cells and cell therapy applications. This includes GMP cryopreservation technology, and high-quality solutions for viral delivery.
